Molecular determinants of response to high-dose androgen therapy in prostate cancer-Reference-Cited by-同舟云学术

Molecular determinants of response to high-dose androgen therapy in prostate cancer

Published:2019-10-03 Issue:19 Volume:4 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Nyquist Michael D.,Corella Alexandra^ORCID,Mohamad Osama^ORCID,Coleman Ilsa,Kaipainen Arja,Kuppers Daniel A.^ORCID,Lucas Jared M.,Paddison Patrick J.,Plymate Stephen R.,Nelson Peter S.,Mostaghel Elahe A.

Funder

U.S. Department of Defense

National Institute of Health USA

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/129715/files/pdf

Reference59 articles.

1. Impact of Androgen Deprivation Therapy on Mental and Emotional Well-Being in Men with Prostate Cancer: Analysis from the CaPSURE™ Registry

2. Abiraterone and Increased Survival in Metastatic Prostate Cancer

3. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

4. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer

5. Bipolar androgen therapy: The rationale for rapid cycling of supraphysiologic androgen/ablation in men with castration resistant prostate cancer

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells;Nature Communications;2024-09-03

2. The protein composition of exosomes released by prostate cancer cells is distinctly regulated by androgen receptor-antagonists and -agonist to stimulate growth of target cells;Cell Communication and Signaling;2024-04-08

3. A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus;Nature Communications;2023-08-23

4. Bipolar Androgen Therapy: When Excess Fuel Extinguishes the Fire;Biomedicines;2023-07-24

5. Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study;Breast Cancer Research and Treatment;2023-07-12